Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;2005(4):316-21.
doi: 10.1155/JBB.2005.316.

Bovine serum albumin antibodies as a disease marker for hepatitis E virus infection

Medhat Haroun  1
Affiliations

Bovine serum albumin antibodies as a disease marker for hepatitis E virus infection

Medhat Haroun. J Biomed Biotechnol. 2005.

Abstract

This report evaluates the significance of antibody/bovine serum albumin (BSA) interactions as a risk factor for the diagnosis of acute hepatitis E. Serum samples from 40 patients with acute hepatitis E and from 40 age/sex matched healthy adult subjects were tested for IgA, IgG, and IgM by ELISA and by turbidimetric assay. BSA was used as a target to characterize changes in levels of interacting immunoglobulins. Initial results obtained before removal of antibodies that interacted with BSA suggested that HEV patients had increased levels of IgM in their sera. It was found that normal individuals had mean IgA, IgG, and IgM levels of 2.55 mg/mL, 9.80 mg/mL, and 1.73 mg/mL, respectively while HEV patients had mean levels of 2.66 mg/mL, 10.04 mg/mL, and 2.01 mg/mL ($P < .26$ , $P < .32$, and $P < .0004$). However, the mean level of IgM in HEV-infected sera after purification from antibodies that interacted with BSA was determined to be 1.72 mg/mL indicating that there was no significant difference in IgM level in HEV patients compared to normal individuals ($P < .6$). The presence of antibodies that interact with BSA might serve as a diagnostic tool for detection of high-risk patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immuno-precipitation and polyacrylamide gel electrophoresis of human serum samples with anti-human IgM. Three HEV-infected serum samples were immuno-precipitated with anti-IgM antiserum developed in rabbit in the absence (lanes A, B, and C resp) or presence of BSA (lanes F, E, and D resp). Lane H contained one normal serum sample in the absence of BSA and Lane G contained the same normal serum sample in the presence of BSA. Lane I represents standard human IgM. H indicates positions of immunoglobulin heavy chains. The precipitates were washed, dissolved in Laemmli sample buffer, and analyzed by polyacrylamide gel electrophoresis.
Figure 2
Figure 2
Serum IgM levels in groups of HEV-infected sera and unaffected control measured by ELISA. Comparison of average serum IgM (mean ± SD).
See this image and copyright information in PMC

References

    1. Bradley D, Andjaparidze A, Cook E.H, Jr, et al. Aetiological agent of enterically transmitted non-A, non-B hepatitis. J Gen Virol. 1988;69(3):731–738. - PubMed
    1. Kane M.A, Bradley D.W, Shrestha S.M, et al. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets. JAMA. 1984;252(22):3140–3145. - PubMed
    1. Bryan J.P, Tsarev S.A, Iqbal M, et al. Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis. 1994;170(3):517–521. - PubMed
    1. Seriwatana J, Shrestha M.P, Scott R.M, et al. Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol. 2002;9(5):1072–1078. - PMC - PubMed
    1. Thomas D.L, Yarbough P.O, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol. 1997;35(5):1244–1247. - PMC - PubMed

LinkOut - more resources